Primary membranous nephropathy (MN) is an autoimmune disease mainly caused by
autoantibodies against the recently discovered podocyte antigens: the M-type …

Membranous nephropathy is a major cause of nephrotic syndrome of non-diabetic origin in
adults. It is the second or third leading cause of end-stage renal disease in patients with …

Objective: To describe the response to rituximab in patients with treatment-resistant chronic
inflammatory demyelinating polyneuropathy (CIDP) with antibodies against paranodal …

The phospholipase A2 receptor (PLA2R1) is the major autoantigen in idiopathic
membranous nephropathy. However, the value of anti-PLA2R1 antibody titers in predicting …

Background The optimal timing and duration of immunosuppressive therapy for idiopathic
membranous nephropathy (iMN) have been debated. This study aimed to evaluate whether …

In patients with membranous nephropathy, alkylating agents (cyclophosphamide or
chlorambucil) alone or in combination with steroids achieve remission of nephrotic …

Membranous nephropathy (MN) describes a histopathologic pattern of injury marked by
glomerular subepithelial immune deposits and collectively represents one of the most …

Lessons from an animal model that faithfully resembles human membranous nephropathy
(MN) have informed our understanding of the pathogenesis of this organ-specific …

As recently as 2002, most cases of primary membranous nephropathy (MN), a relatively
common cause of nephrotic syndrome in adults, were considered idiopathic. We now …

Background The presence of antibodies against the M-type phospholipase A2 receptor
(PLA2R-AB) is considered to be a promising serological diagnostic biomarker of idiopathic …